Fatty liver disease is India’s silent epidemic
Published on: July 10, 2026, 7:29 a.m. | Source: Hindustan Times
India needs to treat metabolic dysfunction-associated steatotic liver disease (MASLD) as a public health threat.
ePrescribe
Upgrade your clinic to smart, simple, and paperless management—start today!
One Partner for All Your Financial Goals
From financial planning and insurance to portfolio management and retirement solutions—get everything under one trusted roof.
Book Consultation